| 1 |
Asad S, Jacobsen A, Teleki A. Inorganic nanoparticles for oral drug delivery: opportunities, barriers, and future perspectives. Current Opinion in Chemical Engineering 2022;38:100869. [DOI: 10.1016/j.coche.2022.100869] [Reference Citation Analysis]
|
| 2 |
Choy C, Lim LY, Chan LW, Cui Z, Mao S, Wong TW. Exploring Intestinal Surface Receptors in Oral Nanoinsulin Delivery. Pharmacol Rev 2022;74:962-83. [PMID: 36779351 DOI: 10.1124/pharmrev.122.000631] [Reference Citation Analysis]
|
| 3 |
Leung KS, Shirazi S, Cooper LF, Ravindran S. Biomaterials and Extracellular Vesicle Delivery: Current Status, Applications and Challenges. Cells 2022;11:2851. [DOI: 10.3390/cells11182851] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 4 |
Cheng H, Wu H, Guo T, Jin Park H, Li J. Zinc insulin hexamer loaded alginate zinc hydrogel: preparation, characterization and in vivo hypoglycemic ability. Eur J Pharm Biopharm 2022:S0939-6411(22)00183-7. [PMID: 36087882 DOI: 10.1016/j.ejpb.2022.08.016] [Reference Citation Analysis]
|
| 5 |
Puri V, Kaur VP, Singh A, Singh C. Recent advances on drug delivery applications of mucopenetrative/mucoadhesive particles: A review. Journal of Drug Delivery Science and Technology 2022;75:103712. [DOI: 10.1016/j.jddst.2022.103712] [Reference Citation Analysis]
|
| 6 |
Subramanian DA, Langer R, Traverso G. Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems. J Nanobiotechnology 2022;20:362. [PMID: 35933341 DOI: 10.1186/s12951-022-01539-x] [Reference Citation Analysis]
|
| 7 |
Zhang J, Liu X, Lin J, Bao X, Peng J, Gong Z, Luan X, Chen Y. Biomimetic engineered nanocarriers inspired by viruses for oral-drug delivery. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121979] [Reference Citation Analysis]
|
| 8 |
Asal HA, Shoueir KR, El-Hagrasy MA, Toson EA. Controlled synthesis of in-situ gold nanoparticles onto chitosan functionalized PLGA nanoparticles for oral insulin delivery. Int J Biol Macromol 2022;209:2188-96. [PMID: 35504421 DOI: 10.1016/j.ijbiomac.2022.04.200] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 9 |
Vitulo M, Gnodi E, Meneveri R, Barisani D. Interactions between Nanoparticles and Intestine. IJMS 2022;23:4339. [DOI: 10.3390/ijms23084339] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Li Y, Zhang W, Zhao R, Zhang X. Advances in oral peptide drug nanoparticles for diabetes mellitus treatment. Bioact Mater 2022;15:392-408. [PMID: 35386357 DOI: 10.1016/j.bioactmat.2022.02.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 11 |
Liu Z, Zhao L, Tan X, Wu Z, Zhou N, Dong N, Zhang Y, Yin T, He H, Gou J, Tang X, Gao S. Preclinical evaluations of Norcantharidin liposome and emulsion hybrid delivery system with improved encapsulation efficiency and enhanced antitumor activity. Expert Opin Drug Deliv 2022. [PMID: 35385376 DOI: 10.1080/17425247.2022.2063834] [Reference Citation Analysis]
|
| 12 |
Zaiki Y, Lim LY, Wong TW. Critical material designs for mucus- and mucosa-penetrating oral insulin nanoparticle development. International Materials Reviews. [DOI: 10.1080/09506608.2022.2040293] [Reference Citation Analysis]
|
| 13 |
Sun J, Xu Z, Hou Y, Yao W, Fan X, Zheng H, Piao J, Li F, Wei Y. Hierarchically structured microcapsules for oral delivery of emodin and tanshinone IIA to treat renal fibrosis. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121490] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Ndayishimiye J, Cao Y, Kumeria T, Blaskovich MAT, Falconer JR, Popat A. Engineering mesoporous silica nanoparticles towards oral delivery of vancomycin. J Mater Chem B 2021;9:7145-66. [PMID: 34525166 DOI: 10.1039/d1tb01430g] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 15 |
Porfiryeva NN, Semina II, Salakhov IA, Moustafine RI, Khutoryanskiy VV. Mucoadhesive and mucus-penetrating interpolyelectrolyte complexes for nose-to-brain drug delivery. Nanomedicine 2021;37:102432. [PMID: 34186258 DOI: 10.1016/j.nano.2021.102432] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 16 |
Fu W, Liang Y, Xie Z, Wu H, Zhang Z, Lv H. Preparation and evaluation of lecithin/zein hybrid nanoparticles for the oral delivery of Panax notoginseng saponins. Eur J Pharm Sci 2021;164:105882. [PMID: 34000426 DOI: 10.1016/j.ejps.2021.105882] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 17 |
Wang Y, Gou K, Guo X, Ke J, Li S, Li H. Advances in regulating physicochemical properties of mesoporous silica nanocarriers to overcome biological barriers. Acta Biomater 2021;123:72-92. [PMID: 33454385 DOI: 10.1016/j.actbio.2021.01.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 18 |
Yan L, Wei L, Zheng W, Liu S, Yin L, Liu C, Zheng L. Oral Delivery of Chitosan Derivative-Based Nanoparticles Encapsulating Quercetin to Attenuate Intestinal Injury and Regulate Gut Microbiota Dysbiosis in Mucositis Treatment. ACS Food Sci Technol 2021;1:399-409. [DOI: 10.1021/acsfoodscitech.0c00121] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
